课题基金 / 基金详情

SCH: INT: Collaborative Research: Patient Specific Multisite Pacing of Diseased Human Hearts

SCH: INT: Collaborative Research: Patient Specific Multisite Pacing of Diseased Human Hearts
SCH:INT:合作研究:患病人类心脏的患者特定多部位起搏
批准号:
1838873
负责人:
Behnaam Aazhang
金额:
$121.41万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-10-01 至 2023-09-30

项目摘要

项目成果

Behnaam Aazhang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cardiovascular disease is the number one cause of death worldwide. For example, heart failure is a significant source of mortality within the U.S; it is responsible for 1% of all emergency room presentations and contributes to one in every nine deaths. A significant proportion of heart failure patients have concurrent conduction system disease, which will lead to their eventual death. Cardiac resynchronization has proven to be a useful therapy for improving cardiac function as well as reducing mortality in some patients. However, a significant number of patients fail to respond to resynchronization therapy, often due to inadequate pacemaker lead placement. There currently exists no pacemaker system that provides the 'potential' benefits of multisite temporally and spatially precise pacing for resynchronization. To reach the audacious goal of eliminating cardiovascular diseases, new technologies must be developed that will monitor the diseased heart with unprecedented temporal and spatial precision and will manage the pacing of the heart to restore a healthy function of the heart. This project will process data recorded from multiple sites and will generate a pacing therapy specific to the patient in real-time.The award revisits the core foundation of pacemakers to develop temporally and spatially precise pacing at multiple sites for resynchronization. The researchers will develop a robust, well-annotated database of intra-cardiac electrograms (IEGM) from multiple cardiac sites. The focus will be on identifying challenging cases that are clinically difficult to differentiate and, thus, stand to reap the greatest benefit of being able to direct overall algorithm development. This information will be added to the associated metadata file. Data will be collected from a minimum of 150 patients with at least 50 patients from each identified pathophysiology. Pathology of each patient based on data from multiple intra-cardiac recording sites will be identified. The proposed machine-learning pipeline explores the representation of time series using wavelets and then learns transformations of multiple time series using the Lie group framework. This pipeline clusters time-series data to identify the right pathology for the specific patient. In addition, the project explores implementation as an application specific integrated circuit (ASIC) that will be implanted subcutaneously to continuously process intracardiac multi-site recordings as well as to generate temporally and spatially precise pacing patterns. The overall approach is to holistically develop a methodology that can address an extremely low-power implementation of machine learning and signal processing algorithms, by not only combining, but jointly optimizing, algorithmic-, circuit- and architecture-level innovations.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.48550/arxiv.2206.00843
发表时间: 2022-06
期刊:
影响因子: --
作者: [Y. Fu;Haichuan Yang;Jiayi Yuan;Meng Li;Cheng Wan;Raghuraman Krishnamoorthi;Vikas Chandra;Yingyan Lin]
通讯作者: Y. Fu;Haichuan Yang;Jiayi Yuan;Meng Li;Cheng Wan;Raghuraman Krishnamoorthi;Vikas Chandra;Yingyan Lin
e-G2C: A 0.14-to-8.31 µJ/Inference NN-based Processor with Continuous On-chip Adaptation for Anomaly Detection and ECG Conversion from EGM
e-G2C:一款基于 0.14 至 8.31 µJ/推理神经网络的处理器,具有连续片上自适应功能,用于 EGM 的异常检测和 ECG 转换
DOI: 10.1109/vlsitechnologyandcir46769.2022.9830335
发表时间: 2022
期刊: 2022 IEEE Symposium on VLSI Technology and Circuits (VLSI Technology and Circuits
影响因子: --
作者: [Zhao, Yang, Zhang, Yongan, Fu, Yonggan, Ouyang, Xu, Wan, Cheng, Wu, Shang, Banta, Anton, John, Mathews M., Post, Allison, Razavi, Mehdi]
通讯作者: Razavi, Mehdi
DOI: --
发表时间: 2019-05
期刊:
影响因子: --
作者: [Randall Balestriero;Romain Cosentino;B. Aazhang;Richard Baraniuk]
通讯作者: Randall Balestriero;Romain Cosentino;B. Aazhang;Richard Baraniuk
DOI: 10.1145/3465372
发表时间: 2021-11
期刊: ACM Journal on Emerging Technologies in Computing Systems (JETC)
影响因子: --
作者: [Yongan Zhang;Anton Banta;Yonggan Fu;M. John;A. Post;M. Razavi;Joseph R. Cavallaro;B. Aazhang;Yingyan Lin]
通讯作者: Yongan Zhang;Anton Banta;Yonggan Fu;M. John;A. Post;M. Razavi;Joseph R. Cavallaro;B. Aazhang;Yingyan Lin
6
    I-Corps: minimally invasive deep brain stimulation using temporally interfering electromagnetic waves
    • 批准号:
      2328599
    • 项目类别:
      Standard Grant
    • 资助金额:
      $5.0万
    • 财政年份:
      2023
    • 负责人:
      Behnaam Aazhang
    • 依托单位:
    EARS: Collaborative Research: Full-Duplex Cognitive Radio: A New Design Paradigm for Enhancing Spectrum Usage
    • 批准号:
      1547305
    • 项目类别:
      Standard Grant
    • 资助金额:
      $20.0万
    • 财政年份:
      2015
    • 负责人:
      Behnaam Aazhang
    • 依托单位:
    NeTS: Small: Collaborative Research: A Service Centric Architecture for Efficient Spectral Utilization in Wireless Networks
    • 批准号:
      1527811
    • 项目类别:
      Standard Grant
    • 资助金额:
      $25.0万
    • 财政年份:
      2015
    • 负责人:
      Behnaam Aazhang
    • 依托单位:
    NCS-FO: Collaborative Research: Micro-scale Real-time Decoding and Closed-loop Modulation of Human Language
    • 批准号:
      1533688
    • 项目类别:
      Standard Grant
    • 资助金额:
      $72.0万
    • 财政年份:
      2015
    • 负责人:
      Behnaam Aazhang
    • 依托单位:
    国内基金
    海外基金
    内源性逆转录病毒MER65-int调控人类胎 盘发育与子宫内膜重塑的功能研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      屈雨亮
    • 依托单位:
    隐秘重组信号序列INT-RSS在T细胞受体基因Tcra重排中的功能和机制研究
    • 批准号:
      32370939
    • 项目类别:
      面上项目
    • 资助金额:
      50万元
    • 批准年份:
      2023
    • 负责人:
      郝冰涛
    • 依托单位:
    HPV16 E7 通过 Int1 蛋白调控 Wnt 信号通路调节肿瘤局部树突状细胞活性
    • 批准号:
      LQ22H160033
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2021
    • 负责人:
      陈婷婷
    • 依托单位:
    选择性PPARγ激动剂INT131调控适应性产热和AD-MSCs分化成棕色样脂肪细胞的机制研究